- Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines2014 | First Faculty of Medicine
- Inclisiran: the first siRNA approved by European Medicines Agency for treatment of dyslipidemias2021 | First Faculty of Medicine
- Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN networkPublication without faculty affiliation
- Biosimilar treatment in paediatric gastroenterology - current view2022 | Second Faculty of Medicine
- Biosimilars - therapeutic value, regulation, the role of pharmacists +12019 | Publication without faculty affiliation
- Toward the risk of respiration depression after codeine and dihydrocodeine2014 | Third Faculty of Medicine
- Lung damage in systemic sclerosis, new indication of antifibrotic treatment with nintedanib2020 | Faculty of Medicine in Hradec Králové
- Rare diseases in terms of pharmacoeconomics2012 | Publication without faculty affiliation
- On the question of the interchangeability of monoclonal biosimilar antibodies in the treatment of immune-mediated inflammatory diseases2023 | First Faculty of Medicine, Third Faculty of Medicine
- Nivolumab in the treatment of metastatic melanoma2015 | Publication without faculty affiliation
- Merkel cell carcinoma - new treatment options2018 | First Faculty of Medicine
- Ocrelizumab - pharmacoloical profile2018 | Faculty of Medicine in Pilsen
- Dapagliflozin a studie DECLARE-TIMI 58: základní charakteristika2018 | First Faculty of Medicine
- Guidelines for the management of acne: recommendations from a French multidisciplinary group2018 | Faculty of Medicine in Pilsen
- Osimertinib - a new oral third-generation EGFR TKI2017 | Publication without faculty affiliation
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study2018 | First Faculty of Medicine
- Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study2020 | Faculty of Medicine in Pilsen
- Lasting effect of pazopanib in first-line treatment of renal cell carcinoma2015 | First Faculty of Medicine
- The position of aliskiren on cardiovascular disease in the light of the ALTITUDE study.2012 | First Faculty of Medicine
- Atezolizumab in the treatment of lung cancer2021 | Publication without faculty affiliation
- Lexicon of available vaccines in the Czech Republic2010 | Faculty of Medicine in Hradec Králové
- Belimumab in the therapy of systemic lupus erythematosus and other indications2014 | First Faculty of Medicine
- Treatment of patients with recurrent/refractory aggressive non-Hodgkin's lymphoma: effectiveness and safety of pixantrone2016 | Faculty of Medicine in Hradec Králové
- Brexpiprazole +12019 | Publication without faculty affiliation
- What has the SIGNIFY trial shown?2015 | First Faculty of Medicine
- Durvalumab in the treatment of lung cancer2019 | Second Faculty of Medicine
- European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy2020 | Second Faculty of Medicine
- What are biosimilars and what do they bring to us?2015 | Third Faculty of Medicine